Nov 12, 2019 / 06:30PM GMT
Matthew Stephan Miksic - Crédit Suisse AG - Research Division - Senior Research Analyst
Okay. So my name is Matt Miksic, medical device analyst at Crédit Suisse. Very pleased to have with us here, Baxter, Jay Saccaro, EVP and CFO; as well as Clare Trachtman, VP, Director, IR extraordinaire.
Questions and Answers:
Matthew Stephan Miksic - Crédit Suisse AG - Research Division - Senior Research AnalystSo there has been a -- it's been a bit of a news build, you could say, Q3 reporting season for a number of companies in our space, Baxter being one of them. Before we kind of dive into sort of maybe the obvious topic, which we do have to kind of touch on, I wanted to give, Jay, you an opportunity as you have done a number of times as we've talked -- caught up after Q3 on what you thought was -- and I think there were some very strong aspects of results, very encouraging aspects of results, and maybe highlight some of those, and then we'll delve into what needs to be flushed out or fixed or clarified over